New Jersey-based PDI has acquired RedPath Integrated Pathology, a Pittsburgh-based firm that specializes in developing tests that focus on diagnosing and managing gastrointestinal cancers. The deal will give PDI exclusive rights over one test that RedPath has already developed, PathFinderTG. It determines the risk among patients of developing cancer for pancreatic cysts, which generates about…
Industry Buzz: PDI Acquires RedPath Integrated Pathology
New Jersey-based PDI has acquired RedPath Integrated Pathology, a Pittsburgh-based firm that specializes in developing tests that focus on diagnosing and managing gastrointestinal cancers. The deal will give PDI exclusive rights over one test that RedPath has already developed, PathFinderTG. It determines the risk among patients of developing cancer for pancreatic cysts, which generates about […]